Literature DB >> 28434742

Endocrine and metabolic changes in transition dairy cows are affected by prepartum infusions of a serotonin precursor.

Lorenzo E Hernández-Castellano1, Laura L Hernandez2, Helga Sauerwein3, Rupert M Bruckmaier4.   

Abstract

Serotonin (5-HT) has been shown to be involved in calcium homeostasis, modulating calcium concentration in blood. In addition, 5-HT participates in a variety of metabolic pathways, mainly through the modulation of glucose and lipid metabolism. The hypothesis of the present study was that the prepartum administration of 5-hydroxy-l-tryptophan (5-HTP), a 5-HT precursor, would affect endocrine systems related to calcium homeostasis, and interact with other endocrine and metabolic pathways during the transition period. In this study, 20 Holstein dairy cows were randomly assigned to 2 experimental groups. Both groups received a daily i.v. infusion of 1 L of either 0.9% NaCl (control group; n = 10) or 0.9% NaCl containing 1 mg of 5-HTP/kg of BW (5-HTP group, n = 10). Infusions started d 10 before estimated parturition date and ended the day of parturition, resulting in a minimum of 4 d of infusion (8.4 ± 0.7 d of infusion). Until parturition, blood samples were collected before the daily infusions, and postpartum daily until d 7, and on d 30. Plasma concentrations of parathyroid hormone (PTH) were transiently increased at parturition and on d 1 in control cows. In the 5-HTP group PTH remained unchanged. The concentration of pyridinoline (PYD), an established marker for calcium release from the bone to the bloodstream, increased on d 1 postpartum only in the 5-HTP group. In control cows, PYD concentrations did not change on d 1 postpartum. Melatonin concentrations were slightly but significantly increased in the 5-HTP group compared with the control group. Insulin concentrations decreased in both groups postpartum. Before parturition, leptin concentrations decreased in both groups and remained at this level until d 30 postpartum. Plasma IgG concentrations decreased in both groups on d -1 postpartum. Haptoglobin increased in both groups on d -1 and remained at this level until d 7 postpartum. No differences between groups were observed for insulin, glucagon, IgG, leptin, adiponectin, and haptoglobin concentrations. The results obtained in the present study evidenced that 5-HT is regulating calcium homeostasis independent of PTH. The lack of treatment effects on IgG and on other hormones and metabolites indicates that 5-HTP did not affect these other metabolic pathways and the IgG concentration during the transition period.
Copyright © 2017 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5-hydroxy-l-tryptophan; hypocalcemia; metabolism; parathyroid hormone; serotonin

Mesh:

Substances:

Year:  2017        PMID: 28434742     DOI: 10.3168/jds.2016-12441

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  11 in total

1.  Selected reaction monitoring mass spectrometry of mastitis milk reveals pathogen-specific regulation of bovine host response proteins.

Authors:  Ulrike Kusebauch; Lorenzo E Hernández-Castellano; Stine L Bislev; Robert L Moritz; Christine M Røntved; Emøke Bendixen
Journal:  J Dairy Sci       Date:  2018-04-11       Impact factor: 4.034

Review 2.  Assessing mineral status in edible tissues of domestic and game animals: a review with a special emphasis in tropical regions.

Authors:  D M Ribeiro; M P Mourato; A M Almeida
Journal:  Trop Anim Health Prod       Date:  2019-03-07       Impact factor: 1.559

Review 3.  TRIENNIAL LACTATION SYMPOSIUM/BOLFA: Serotonin and the regulation of calcium transport in dairy cows.

Authors:  L L Hernandez
Journal:  J Anim Sci       Date:  2017-12       Impact factor: 3.159

4.  Effect of induced hypocalcemia in nonlactating, nonpregnant Holstein cows fed negative DCAD with low, medium, or high concentrations of calcium.

Authors:  Laura A Amundson; Angela D Rowson; Peter M Crump; Austin P Prichard; Adrienne A Cheng; Collin E Wimmler; Marisa Klister; Samantha R Weaver; Scott S Bascom; Dennis E Nuzback; Ken P Zanzalari; Laura L Hernandez
Journal:  J Anim Sci       Date:  2018-12-03       Impact factor: 3.159

Review 5.  Limiting factors for milk production in dairy cows: perspectives from physiology and nutrition.

Authors:  Josef J Gross
Journal:  J Anim Sci       Date:  2022-03-01       Impact factor: 3.159

6.  The relationship between body condition score, thyroxin, and health condition and serum energy indices, insulin like growth factor-1, and lipids profile over the transition period in Holstein dairy cows.

Authors:  F Dehghan Shahreza; H A Seifi; M Mohri
Journal:  Iran J Vet Res       Date:  2022       Impact factor: 1.226

Review 7.  Could use of Selective Serotonin Reuptake Inhibitors During Lactation Cause Persistent Effects on Maternal Bone?

Authors:  Samantha R Weaver; Laura L Hernandez
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-03-30       Impact factor: 2.673

8.  The comparative effects of dietary monensin and propylene glycol on insulin resistance of transition dairy cows.

Authors:  Aliasghar Chalmeh; Mehrdad Pourjafar; Khalil Badiei; Mohammad Jalali; Mohammad Mazrouei Sebdani
Journal:  Trop Anim Health Prod       Date:  2019-12-10       Impact factor: 1.559

9.  Effect of yeast products supplementation during transition period on metabolic profile and milk production in dairy cows.

Authors:  Claudia Faccio-Demarco; Tatiele Mumbach; Vanessa Oliveira-de-Freitas; Raquel Fraga E Silva-Raimondo; Fernanda Medeiros-Gonçalves; Marcio Nunes-Corrêa; Francisco Augusto Burkert-Del Pino; Henrique Mendonça-Nunes-Ribeiro Filho; Cássio Cassal-Brauner
Journal:  Trop Anim Health Prod       Date:  2019-05-24       Impact factor: 1.893

10.  Pharmacologic inhibition of mTORC1 mimics dietary protein restriction in a mouse model of lactation.

Authors:  Virginia L Pszczolkowski; Steven J Halderson; Emma J Meyer; Amy Lin; Sebastian I Arriola Apelo
Journal:  J Anim Sci Biotechnol       Date:  2020-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.